EC Number | Application | Comment | Organism |
---|---|---|---|
1.2.1.11 | drug development | the enzyme is a validated target for antimicrobial drug design | Cryptococcus neoformans var. neoformans |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.2.1.11 | gene CNA02450, codon-optimized, recombinant expression of C-terminally His-tagged enzyme ASADH in Escherichia coli strain BL21(DE3) | Cryptococcus neoformans var. neoformans |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
1.2.1.11 | purified recombinant C-terminally His-tagged enzyme, hanging drop vapour diffusion method, crystallization screening, mixing of 9 mg/ml protein solution with reservoir solution containing 10% PEG 8000, 6% ethylene glycol, 0.1 M HEPES pH 7.5, in a 2:1 ration, at 20°C, crystals are cocrystallized with 4 mM NADP+, X-ray diffraction structure determination and analysis at 2.6 A resolution, modeling by molecular replacement | Cryptococcus neoformans var. neoformans |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
1.2.1.11 | 160000 | - |
recombinant His-tagged enzyme, gel filtration | Cryptococcus neoformans var. neoformans |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.2.1.11 | L-aspartate 4-semialdehyde + phosphate + NADP+ | Cryptococcus neoformans var. neoformans | - |
L-4-aspartyl phosphate + NADPH + H+ | - |
r | |
1.2.1.11 | L-aspartate 4-semialdehyde + phosphate + NADP+ | Cryptococcus neoformans var. neoformans ATCC MYA-565 | - |
L-4-aspartyl phosphate + NADPH + H+ | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.2.1.11 | Cryptococcus neoformans var. neoformans | Q5KPK7 | serotype D | - |
1.2.1.11 | Cryptococcus neoformans var. neoformans ATCC MYA-565 | Q5KPK7 | serotype D | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.2.1.11 | recombinant C-terminally His-tagged enzyme ASADH from Escherichia coli strain BL21(DE3) by nickel affinity chromatography, dialysis, and ultrafiltration | Cryptococcus neoformans var. neoformans |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.2.1.11 | L-aspartate 4-semialdehyde + phosphate + NADP+ | - |
Cryptococcus neoformans var. neoformans | L-4-aspartyl phosphate + NADPH + H+ | - |
r | |
1.2.1.11 | L-aspartate 4-semialdehyde + phosphate + NADP+ | - |
Cryptococcus neoformans var. neoformans ATCC MYA-565 | L-4-aspartyl phosphate + NADPH + H+ | - |
r |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
1.2.1.11 | More | enzyme secondary structure, crystal structure analysis and comparisons, the C-terminal domain consists of six beta-strands, six alpha-helices and a single 310-helix that represent the catalytic site and the dimerization interface, detailed overview | Cryptococcus neoformans var. neoformans |
1.2.1.11 | tetramer | dimer of dimers, 4 * 40000, about, recombinant His-tagged enzyme, SDS-PAGE | Cryptococcus neoformans var. neoformans |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.2.1.11 | ASADH | - |
Cryptococcus neoformans var. neoformans |
1.2.1.11 | CNA02450 | - |
Cryptococcus neoformans var. neoformans |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.2.1.11 | 8.6 | - |
assay at | Cryptococcus neoformans var. neoformans |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.2.1.11 | NADP+ | the NADP+-binding domain consists of mixed beta-strands flanked on both sides with alpha-helices, with seven beta-strands, five alpha-helices and two 310-helices | Cryptococcus neoformans var. neoformans | |
1.2.1.11 | NADPH | - |
Cryptococcus neoformans var. neoformans |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.2.1.11 | metabolism | aspartate-semialdehyde dehydrogenase catalyzes the reductive dephosphorylation of the substrate beta-aspartyl phosphate into aspartate semialdehyde, a key intermediate in the aspartate biosynthetic pathway and functions at a critical junction in the aspartate biosynthetic pathway | Cryptococcus neoformans var. neoformans |
1.2.1.11 | additional information | The structure of CnASADH belongs to the Rossmann-fold superfamily of pyridine-linked dehydrogenases and shares the same overall monomeric structural features as the other ASADHs for which structures are determined | Cryptococcus neoformans var. neoformans |
1.2.1.11 | physiological function | the enzyme catalyzes the NADPH-dependent reductive dephosphorylation of 4-aspartyl phosphate to produce the key intermediate aspartate semialdehyde | Cryptococcus neoformans var. neoformans |